IP Library Assignment 057988/0110
Patent Assignment
Reel/Frame 057988/0110

Security Interest

Recorded: 2021-11-02 Pages: 11
Assignors
INTERPACE BIOSCIENCES, INC.
Executed: 2021-11-01
INTERPACE DIAGNOSTICS CORPORATION
Executed: 2021-11-01
INTERPACE DIAGNOSTICS, LLC
Executed: 2021-11-01
INTERPACE PHARMA SOLUTIONS, INC.
Executed: 2021-11-01
Assignee
BROADOAK FUND V, L.P.
4800 MONTGOMERY LANE, SUITE 230, BETHESDA, MARYLAND, 20814
Covered Properties (31)
Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
Application: 13/299,226 →
Publication: US 2012/0157334
Methods and Compositions Involving Mir-135B for Distinguishing Pancreatic Cancer from Benign Pancreatic Disease
Patent: 9,644,241 →
Application: 13/615,066 →
Publication: US 2013/0157272
Methods for Treating Barrett's Metaplasia and Esophageal Adenocarcinoma
Application: 13/692,727 →
Publication: US 2013/0143222
Methods for Treating Barrett's Metaplasia and Esophageal Adenocarcinoma
Application: 13/954,247 →
Publication: US 2013/0317317
Methods for Measuring Carcinoembryonic Antigen
Patent: 9,341,628 →
Application: 14/092,036 →
Publication: US 2014/0154698
Methods for Measuring Carcinoembryonic Antigen
Application: 15/147,960 →
Publication: US 2017/0089907
Methods and Compositions Involving Mir-135B for Distinguishing Pancreatic Cancer from Benign Pancreatic Disease
Application: 15/491,399 →
Publication: US 2018/0066316
Topographic Genotyping for Determining the Diagnosis, Malignant Potential, and Biologic Behavior of Pancreatic Cysts and Related Conditions
Application: 15/912,654 →
Publication: US 2019/0049452
Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
Application: 16/188,769 →
Publication: US 2019/0309370
Methods for Treating Barrett's Metaplasia and Esophageal Adenocarcinoma
Application: 16/285,604 →
Publication: US 2020/0035324
Methods for Measuring Carcinoembryonic Antigen
Application: 16/558,489 →
Publication: US 2020/0249236
Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
Application: 17/400,660 →
Publication: US 2022/0213551
Topographic genotyping for defining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions
Application: 60/620,926 →
Topographic genotyping for defining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions
Application: 60/631,240 →
Topographic genotyping for determining the diagnosis, malignant potential, and biologic behavior of pancreatic cysts and related conditions
Application: 60/644,568 →
Molecular analysis of cellular fluids specimens for clinical diagnosis, characterization, and integration with microspopic pathology evaluation
Application: 60/679,968 →
Dynamic genomic deletion expansion: a predictor of cancer biological aggressiveness
Application: 60/679,969 →
Micrornas Differentially Expressed in Pancreatic Diseases and Uses Thereof
Application: 60/826,173 →
Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms
Application: 61/414,778 →
Methods and Compositions Involving Mir-135B for Distinguishing Pancreatic Cancer from Benign Pancreatic Disease
Application: 61/534,332 →
Methods and Compositions Involving Mir-135B for Distinguishing Pancreatic Cancer from Benign Pancreatic Disease
Application: 61/536,486 →
Mirnas as Diagnostic Biomarkers to Distinguish Benign from Malignant Thyroid Tumors
Application: 61/552,451 →
Mirnas as Diagnostic Biomarkers to Distinguish Benign from Malignant Thyroid Tumors
Application: 61/552,762 →
Methods of Identifying Dysplasia in a Subject
Application: 61/565,879 →
Methods for Diagnosing Low and High Grade Dysplasia in Barrett's Esophagus
Application: 61/640,527 →
Methods for Diagnosing Low and High Grade Dysplasia in Barrett's Esophagus
Application: 61/661,256 →
Diagnostic Mirnas for Differential Diagnosis of Incidental Pancreatic Cystic Lesions
Application: 61/709,411 →
Diagnostic Mirnas for Differential Diagnosis of Incidental Pancreatic Cystic Lesions
Application: 61/716,396 →
Methods for Measuring Carcinoembryonic Antigen
Application: 61/731,725 →
Methods for Measuring Carcinoembryonic Antigen
Application: 61/824,623 →
Methods for Measuring Carcinoembryonic Antigen
Application: 61/840,963 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 17, 2005
From: FINKELSTEIN, SYDNEY D.
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 016361/0809 →
Assignment of Assignor's Interest Jun 17, 2005
From: FINKELSTEIN, SYDNEY D.
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 016361/0796 →
Assignment of Assignor's Interest Aug 9, 2005
From: FINKELSTEIN, SYDNEY DAVID; SWALSKY, PATRICIA
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 016881/0023 →
Assignment of Assignor's Interest Aug 9, 2005
From: FINKELSTEIN, SYDNEY DAVID; SWALSKY, PATRICIA
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 016880/0922 →
Assignment of Assignor's Interest Aug 12, 2005
From: FINKELSTEIN, SYDNEY DAVID; SWALSKY, PATRICIA
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 016884/0754 →
Assignment of Assignor's Interest Feb 10, 2011
From: BEAUDENON-HUIBREGTSE, SYLVIE; CHOUDHARY, ASHISH
To: ASURAGEN, INC.
Reel/Frame 025786/0275 →
Assignment of Assignor's Interest Jan 21, 2012
From: BEAUDENON-HUIBREGTSE, SYLVIE; CHOUDHARY, ASHISH
To: ASURAGEN, INC.
Reel/Frame 027572/0401 →
Assignment of Assignor's Interest Feb 12, 2013
From: ADAI, ALEX; SZAFRANSKA-SCHWARZBACH, ANNA; ANDRUSS, BERNARD; HAHN, STEPHAN ALBRECHT
To: ASURAGEN, INC.
Reel/Frame 029799/0035 →
Assignment of Assignor's Interest Sep 11, 2013
From: ELLSWORTH, ERIC MATTHEW GAYLE; FINKELSTEIN, SYDNEY DAVID; JACKSON, SARA ANN; CORCORAN, BRENDAN
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 031181/0350 →
Assignment of Assignor's Interest Dec 11, 2013
From: FINKELSTEIN, SYDNEY DAVID; JACKSON, SARA ANN; CORCORAN, BRENDAN; SMITH, DENNIS MORGAN, JR.
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 031755/0853 →
Assignment of Assignor's Interest Jan 2, 2014
From: FINKELSTEIN, SYDNEY DAVID; JACKSON, SARA ANN; BLEICHER, JAMIE MICHELLE; ELLSWORTH, ERIC MATTHEW GAYLE
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 031875/0596 →
Assignment of Assignor's Interest Mar 5, 2014
From: FINKELSTEIN, SYDNEY D.; ELLSWORTH, ERIC MATTHEW GAYLE; JACKSON, SARA A.
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 032350/0613 →
Security Interest Mar 31, 2014
From: REDPATH INTEGRATED PATHOLOGY, INC.
To: SQUARE 1 BANK
Reel/Frame 032564/0363 →
Assignment of Assignor's Interest Aug 25, 2014
From: ASURAGEN, INC.
To: INTERPACE DIAGNOSTICS, LLC
Reel/Frame 033605/0803 →
Assignment of Assignor's Interest Aug 28, 2014
From: ASURAGEN, INC.
To: INTERPACE DIAGNOSTICS, LLC
Reel/Frame 033647/0647 →
Assignment of Assignor's Interest Oct 15, 2014
From: FINKELSTEIN, SYDNEY DAVID
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 033954/0960 →
Assignment of Assignor's Interest Oct 15, 2014
From: ELLSWORTH, ERIC MATTHEW GAYLE
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 033955/0046 →
Assignment of Assignor's Interest Oct 15, 2014
From: CORCORAN, BRENDAN; SMITH, DENNIS MORGAN, JR.
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 033955/0142 →
Assignment of Assignor's Interest Oct 15, 2014
From: JACKSON, SARA ANN
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 033955/0095 →
Release of Security Interest Oct 31, 2014
From: SQUARE 1 BANK
To: REDPATH INTEGRATED TECHNOLOGY, INC.
Reel/Frame 034083/0805 →
Security Interest Nov 4, 2014
From: INTERPACE DIAGNOSTICS, LLC
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 034103/0278 →
Merger and Change of Name Nov 6, 2014
From: REDPATH INTEGRATED PATHOLOGY, INC.; REDPATH ACQUISITION SUB, INC.; INTERPACE DIAGNOSTICS CORPORATION
To: INTERPACE DIAGNOSTICS CORPORATION
Reel/Frame 034114/0658 →
Assignment of Assignor's Interest Nov 6, 2014
From: FINKELSTEIN, SYDNEY DAVID; JACKSON, SARA ANN; BLEICHER, JAMIE MICHELLE; ELLSWORTH, ERIC MATTHEW GAYLE
To: REDPATH INTEGRATED PATHOLOGY, INC.
Reel/Frame 034118/0136 →
Security Interest Nov 10, 2014
From: INTERSPACE DIAGNOSTICS, LLC; JS GENETICS, INC.; GROUP DCA, LLC; PDI, INC.
To: REDPATH EQUITYHOLDER REPRESENTATIVE, LLC
Reel/Frame 034136/0060 →
Security Interest Nov 10, 2014
From: INTERSPACE DIAGNOSTICS CORPORATION
To: REDPATH EQUITYHOLDER REPRESENTATIVE, LLC
Reel/Frame 034136/0312 →